NCT00157976View on ClinicalTrials.gov

Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration

PHASE3UnknownINTERVENTIONAL
Enrollment

660

Participants

Timeline

Start Date

September 30, 2005

Conditions
Macular Degeneration
Interventions
DRUG

Photrex (rostaporfin)

Trial Locations (4)

Unknown

RECRUITING

Multiple Investigators, Sofia

RECRUITING

Multiple Investigators, Brno-Bohunice, Olomouc, Praha

RECRUITING

Multiple Investigators, Warsaw, Bydgoszcz, Lubin

RECRUITING

Multiple Investigators, Bucharest

Sponsors
All Listed Sponsors
lead

Miravant Pharmaceuticals

INDUSTRY